A detailed history of Covenant Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Covenant Asset Management, LLC holds 6,343 shares of REGN stock, worth $4.53 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
6,343
Previous 6,350 0.11%
Holding current value
$4.53 Million
Previous $6.67 Million 0.09%
% of portfolio
1.06%
Previous 1.07%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1024.09 - $1201.76 $7,168 - $8,412
-7 Reduced 0.11%
6,343 $6.67 Million
Q2 2024

Aug 02, 2024

SELL
$883.2 - $1071.19 $4,416 - $5,355
-5 Reduced 0.08%
6,350 $6.67 Million
Q1 2024

Apr 23, 2024

SELL
$902.69 - $993.35 $9,929 - $10,926
-11 Reduced 0.17%
6,355 $6.12 Million
Q4 2023

Jan 22, 2024

BUY
$775.18 - $881.7 $172,089 - $195,737
222 Added 3.61%
6,366 $5.59 Million
Q3 2023

Oct 31, 2023

BUY
$692.45 - $844.37 $1.34 Million - $1.64 Million
1,940 Added 46.15%
6,144 $5.06 Million
Q2 2023

Jul 12, 2023

BUY
$700.03 - $830.35 $2.66 Million - $3.16 Million
3,804 Added 951.0%
4,204 $3.02 Million
Q4 2022

Jan 24, 2023

SELL
$705.89 - $766.39 $20.2 Million - $22 Million
-28,660 Reduced 98.62%
400 $0
Q3 2022

Nov 03, 2022

BUY
$573.97 - $724.32 $11.8 Million - $14.9 Million
20,572 Added 242.37%
29,060 $3.93 Million
Q2 2022

Jul 21, 2022

SELL
$548.35 - $738.84 $1.71 Million - $2.3 Million
-3,114 Reduced 26.84%
8,488 $5.02 Million
Q1 2022

Apr 29, 2022

SELL
$595.12 - $698.43 $216,623 - $254,228
-364 Reduced 3.04%
11,602 $8.1 Million
Q4 2021

Jan 26, 2022

SELL
$543.48 - $670.97 $7,065 - $8,722
-13 Reduced 0.11%
11,966 $7.56 Million
Q3 2021

Oct 15, 2021

BUY
$574.03 - $680.96 $119,398 - $141,639
208 Added 1.77%
11,979 $7.25 Million
Q2 2021

Jul 21, 2021

BUY
$472.8 - $558.54 $5.11 Million - $6.03 Million
10,800 Added 1112.26%
11,771 $6.58 Million
Q2 2020

Jul 24, 2020

SELL
$493.32 - $643.92 $165,262 - $215,713
-335 Reduced 25.65%
971 $605,000
Q4 2019

Jan 24, 2020

SELL
$274.13 - $376.51 $7,127 - $9,789
-26 Reduced 1.95%
1,306 $490,000
Q3 2019

Oct 18, 2019

SELL
$273.46 - $318.39 $63,989 - $74,503
-234 Reduced 14.94%
1,332 $369,000
Q2 2019

Jul 17, 2019

SELL
$299.6 - $414.82 $36,551 - $50,608
-122 Reduced 7.23%
1,566 $490,000
Q1 2019

Apr 26, 2019

BUY
$372.08 - $439.57 $294,687 - $348,139
792 Added 88.39%
1,688 $693,000
Q3 2018

Oct 09, 2018

SELL
$351.14 - $408.51 $7,725 - $8,987
-22 Reduced 2.4%
896 $362,000
Q2 2018

Jul 12, 2018

SELL
$284.6 - $344.99 $14,230 - $17,249
-50 Reduced 5.17%
918 $317,000
Q1 2018

May 04, 2018

SELL
$315.82 - $393.78 $944,933 - $1.18 Million
-2,992 Reduced 75.56%
968 $333,000
Q4 2017

Jan 12, 2018

SELL
$358.63 - $469.95 $26,897 - $35,246
-75 Reduced 1.86%
3,960 $1.49 Million
Q3 2017

Oct 19, 2017

BUY
$431.38 - $504.0 $1.74 Million - $2.03 Million
4,035
4,035 $1.8 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Covenant Asset Management, LLC Portfolio

Follow Covenant Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Asset Management, LLC with notifications on news.